Literature DB >> 32362213

Characteristics of patients assessed for cognitive decline in primary healthcare, compared to patients assessed in specialist healthcare.

Mona Michelet1,2,3, Anne Lund4, Bjørn Heine Strand1,5, Knut Engedal1,2, Geir Selbaek1,2,3, Sverre Bergh1,6.   

Abstract

Objective: The aim of this study was to describe patients assessed for cognitive decline in primary healthcare, compared to patients assessed in specialist healthcare and to examine factors associated with depression.Design: This was an observational study.Setting: Fourteen outpatient clinics and 33 general practitioners and municipality memory teams across Norway.Subjects: A total of 226 patients assessed in primary healthcare and 1595 patients assessed in specialist healthcare outpatient clinics.Main outcome measures: Cornell scale for depression in dementia (CSDD), Mini-Mental Status Examination (MMSE), Clock drawing test, Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE), Instrumental Activities of Daily Living, Personal Self-Maintenance Scale, Relatives' stress scale (RSS), and Neuropsychiatric Inventory Questionnaire (NPI-Q)
Results: Patients assessed in primary healthcare were older (mean age 81.3 vs 73.0 years), less educated, had poorer cognition (MMSE median 22 vs 25), more limitations in activities of daily living (ADL), more behavioural and psychological symptoms of dementia (BPSD), more depressive symptoms (CSDD median 7 vs 5), more often lived alone (60% vs 41%) and were more often diagnosed with dementia (86% vs 47%) compared to patients diagnosed in specialist healthcare. Depression was associated with female gender, older age, more severe decline in cognitive functioning (IQCODE, OR 1.65), higher caregiver burden (RSS, OR 1.10) and with being assessed in primary healthcare (OR 1.53).
Conclusion: Post-diagnostic support tailored to patients diagnosed with dementia in primary healthcare should consider their poor cognitive function and limitations in ADL and that these people often live alone, have BPSD and depression.Key pointsPeople diagnosed in Norwegian primary healthcare had more needs than people diagnosed in specialist healthcare.  • They were older, less educated, had poorer cognitive functioning and activity limitations, more often lived alone, and had more BPSD and depression.  • Depression was associated with being female, older, having cognitive decline, being assessed in primary care and the caregiver experiencing burden  • Post diagnostic support for people with dementia should be tailored to the individual's symptoms and needs.

Entities:  

Keywords:  Dementia; activities of daily living; depression; diagnostic services; primary health care

Mesh:

Year:  2020        PMID: 32362213     DOI: 10.1080/02813432.2020.1753334

Source DB:  PubMed          Journal:  Scand J Prim Health Care        ISSN: 0281-3432            Impact factor:   2.581


  4 in total

1.  Clock-Drawing Test as a Screening Tool for Cognitive Impairment Associated With Fecal Immunochemical Test Collection Errors.

Authors:  Jeanette M Daly; Yinghui Xu; Seth D Crockett; Megan E Schmidt; Peter Kim; Barcey T Levy
Journal:  Ann Fam Med       Date:  2022 Sep-Oct       Impact factor: 5.707

2.  Time from dementia diagnosis to nursing-home admission and death among persons with dementia: A multistate survival analysis.

Authors:  Marit Mjørud; Geir Selbæk; Espen Bjertness; Trine Holt Edwin; Knut Engedal; Anne-Brita Knapskog; Bjørn Heine Strand
Journal:  PLoS One       Date:  2020-12-04       Impact factor: 3.240

3.  Development of an artificial intelligence-based diagnostic model for Alzheimer's disease.

Authors:  Kazuki Fujita; Masahito Katsuki; Ai Takasu; Ayako Kitajima; Tomokazu Shimazu; Yuichi Maruki
Journal:  Aging Med (Milton)       Date:  2022-09-25

4.  Discrepancies Between Community-Dwelling Individuals with Dementia and Their Proxies in Completing the Cornell Scale for Depression in Dementia: A Secondary Data Analysis.

Authors:  Wing-Yin Leung; Sunil Bhar; Ann Reilly; Sonja Pedell
Journal:  Clin Interv Aging       Date:  2021-02-16       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.